In vitro and in vivo osteoconductivity of bone marrow stromal cells in biomimetic polycaprolactone/calcium phosphate cement composites

Journal of Biomaterials and Tissue Engineering

Volumn 3, Issue 5, 2013, Pages 512-522

  Wang, Shuhong ^a,c,d   Zhao, Peng ^b   Lin, Chao ^b   Huang, Yuanliang ^a,d  

^a First Affiliated Hospital of Fourth Military Medical University   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^d Shanghai Engineering Research Center of Tooth Restoration and Regeneration   (China)

Author keywords

Biocompatibility; Biomimetic; Bone tissue engineering; Scaffold; Stem cell

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; BIOMIMETIC MATERIAL; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CEMENT; OSTEOCALCIN; POLYCAPROLACTONE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BONE CONDUCTION; BONE DEVELOPMENT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYMATIC ASSAY; HEMATOPOIETIC STEM CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; MALE; MECHANICS; MICRO-COMPUTED TOMOGRAPHY; MORPHOLOGY; MTT ASSAY; NONHUMAN; POROSITY; RAT; SCANNING ELECTRON MICROSCOPY; STAINING; TISSUE ENGINEERING;

EID: 84891610892     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2013.1113     Document Type: Article

References (39)

1. C. Eddy, L. Laufe, R. Dunn, and J. Gibson, The use of prostacyclin analogue-containing suture for the prevention of postoperative venous thrombosis in the rat. Plast. Reconstr. Surg. 78, 504 (1986).
2. A. Lendlein and R. Langer, Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296, 1673 (2002).
3. M. D. Weir and H. H. K. Xu, Culture human mesenchymal stem cells with calcium phosphate cement scaffolds for bone repair. J. Mater. Sci.: Mater. Med. 93B, 93 (2010).
4. T. S. N. Silva, B. T. Primo, A. N. Silva, D. C. Machado, C. Viezzer, and L. A. Santos, Use of calcium phosphate cement scaffolds for bone tissue engineering: In vitro study. Acta Cirurgica Brasileira 26, 7 (2011).
5. S. I. Roohani-Esfahani, S. Nouri-Khorasani, Z. F. Lu, R. Appleyard, and H. Zreiqat, The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites. Biomaterials 31, 5498 (2010).
6. C. Makarov, I. Gotman, X. Jiang, S. Fuchs, C. J. Kirkpatrick, and E. Y. Gutmanas, In situ synthesis of calcium phosphatepolycaprolactone nanocomposites with high ceramic volume fractions. J. Mater. Sci.: Mater. Med. 21, 1771 (2010).
7. M. J. Mondrinos, R. Dembzynski, L. Lu, V. K. C. Byrapogu, D. M. Wootton, P. I. Lelkes, and J. Zhou, Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. Biomaterials 27, 4399 (2006).
8. B. T. Lee, D. Van Quang, M. H. Youn, and H. Y. Song, Fabrication of biphasic calcium phosphates/polycaprolactone composites by melt infiltration process. J. Mater. Sci.: Mater. Med. 19, 2223 (2008).
9. J. V. Araujo, A. Martins, I. B. Leonor, E. D. Pinho, R. L. Reis, and N. M. Neves, Surface controlled biomimetic coating of polycaprolactone nanofiber meshes to be used as bone extracellular matrix analogues. J. Biomater. Sci., Polym. Ed. 19, 1261 (2008).
10. W. D. Chan, H. Perinpanayagam, H. A. Goldberg, G. K. Hunter, S. J. Dixon, G. C. Santos, and A. S. Rizkalla, Tissue engineering scaffolds for the regeneration of craniofacial bone. J. Can. Dent. Assoc. 75, 373 (2009).
11. F. Djouad, D. Guerit, M. Marie, K. Toupet, C. Jorgensen, and D. Noel, Mesenchymal stem cells: New insights into bone regenerative applications. J. Biomater. Tissue Eng. 2, 14 (2012).
12. S. Liao, S. Ramakrishna, and M. Ramalingam, Development of nanofiber biomaterials and stem cells in tissue engineering. J. Biomater. Tissue Eng. 1, 111 (2012).
13. A. Ergun, X. Yu, A. Valdevit, A. Ritter, and D. M. Kalyon, Radially and axially graded multizonal bone graft substitutes targeting critical-sized bone defects from polycaprolactone/ hydroxyapatite/tricalcium phosphate. Tissue Eng., Part A 18, 2426 (2012).
14. C. Maniatopoulos, J. Sodek, and A. Melcher, Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254, 317 (1988).
15. Y. F. Zhou, F. L. Chen, S. T. Ho, M. A. Woodruff, T. M. Lim, and D. W. Hutmacher, Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials 28, 814 (2007).
16. Z. Y. Zhang, S. H. Teoh, M. S. K. Chong, J. T. Schantz, N. M. Fisk, M. A. Choolani, and J. Chan, Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27, 126 (2009).
17. L. Zhao, E. F. Burguera, H. H. K. Xu, N. Amin, H. Ryou, and D. D. Arola, Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds. Biomaterials 31, 840 (2010).
18. H. N. Wang, Y. B. Li, Y. Zuo, J. H. Li, S. S. Ma, and L. Cheng, Biocompatibility and osteogenesis of biomimetic nanohydroxyapatite/ polyamide composite scaffolds for bone tissue engineering. Biomaterials 28, 3338 (2007).
19. W. Xia, Y. Li, B. Lou, P. J. Wang, X. L. Gao, and C. Lin, Bioreducible PEI-siRNA nanocomplex for liver cancer therapy: Transfection, biodistribution, and tumor growth inhibition in vivo. J. Nanomater. (2013).
20. W. Xia, P. Wang, C. Lin, Z. Li, X. Gao, G. Wang, and X. Zhao, Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo. J. Control Release 157, 427 (2012).
21. C. Lin, and J. F. J. Engbersen, PEGylated bioreducible poly(amido amine)s for non-viral gene delivery. Mater. Sci. Eng., C 31, 1330 (2011).
22. S. I. Roohani-Esfahani, Z. F. Lu, J. J. Li, R. Ellis-Behnke, D. L. Kaplan, and H. Zreiqat, Effect of self-assembled nanofibrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds. Acta Biomaterialia 8, 302 (2012).
23. B. Mavis, T. T. Demirtas, M. Gumusderelioglu, G. Gunduz, and U. Colak, Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate. Acta Biomater. 5, 3098 (2009).
24. O. Erdemli, O. Captug, H. Bilgili, D. Orhan, A. Tezcaner, and D. Keskin, In vitro and in vivo evaluation of the effects of demineralized bone matrix or calcium sulfate addition to polycaprolactonebioglass composites. J. Mater. Sci.: Mater. Med. 21, 295 (2010).
25. J. R. J. Paletta, F. Mack, H. Schenderlein, C. Theisen, J. Schmitt, J. H. Wendorff, S. Agarwal, S. Fuchs-Winkelmann, and M. D. Schofer, Incorporation of osteoblasts (MG63) into 3D nanofibre matrices by simultaneous electrospinning and spraying in bone tissue engineering. Eur. Cells Mater. 21, 384 (2011).
26. D. H. Zou, Z. Y. Zhang, J. C. He, S. H. Zhu, S. Y. Wang, W. J. Zhang, J. Zhou, Y. J. Xu, Y. Huang, Y. Y. Wang, W. Han, Y. Zhou, S. H. Wang, S. L. You, X. Q. Jiang, and Y. L. Huang, Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1 alpha and a phosphate cement scaffold. Biomaterials 32, 9707 (2011).
27. D. H. Zou, Z. Y. Zhang, D. X. Ye, A. F. Tang, L. F. Deng, W. Han, J. Zhao, S. H. Wang, W. J. Zhang, C. Zhu, J. Zhou, J. C. He, Y. Y. Wang, F. Xu, Y. L. Huang, and X. Q. Jiang, Repair of criticalsized rat calvarial defects using genetically engineered bone marrowderived mesenchymal stem cells overexpressing hypoxia-Inducible factor-1 alpha. Stem Cells 29, 1380 (2011).
28. S. I. Roohani, Z. F. Lu, J. J. Li, R. Ellis-Behnke, D. L. Kaplan, and H. Zreiqat, Effect of self-assembled nanofibrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds. Acta Biomater. 8, 302 (2012).
29. R. Jin, B. Lou, and C. Lin, Tyrosinase-mediated in situ forming hydrogels from biodegradable chondroitin sulfate-tyramine conjugates. Polym. Int. 62, 353 (2013).
30. Y. Y. Sun, Z. F. Deng, Y. Tian, and C. Lin, Horseradish peroxidasemediated in situ forming hydrogels from degradable tyramine-based poly(amido amine)s. J. Appl. Polym. Sci. 127, 40 (2013).
31. F. Li, Q. J. Ba, S. M. Niu, Y. Guo, Y. K. Duan, P. Zhao, C. Lin, and J. Sun, In-situ forming biodegradable glycol chitosan-based hydrogels: Synthesis, characterization, and chondrocyte culture. Mater. Sci. Eng., C 32, 2017 (2012).
32. V. V. Seregin and J. L. Coffer, Biomineralization of calcium disilicide in porous polycaprolactone scaffolds. Biomaterials 27, 4745 (2006).
33. P. Borbely, K. Gulabivala, and J. C. Knowles, Degradation properties and ion release characteristics of Resilon (R) and phosphate glass/polycaprolactone composites. International Endodontic Journal 41, 1093 (2008).
34. V. Lekovic and E. B. Kenney, Guided tissue regeneration using calcium phosphate implants together with 4 different membranes. A study on furcations in dogs. Journal of Periodontology 64, 1154 (1993).
35. V. Guarino, V. Cirillo, P. Taddei, M. A. Alvarez-Perez, and L. Ambrosio, Tuning size scale and crystallinity of PCL electrospun fibres via solvent permittivity to address hMSC response. Macromol. Biosci. 11, 1694 (2011).
36. M. S. Mohammadi, I. Ahmed, N. Muja, S. Almeida, C. D. Rudd, M. N. Bureau, and S. N. Nazhat, Effect of Si and Fe doping on calcium phosphate glass fibre reinforced polycaprolactone bone analogous composites. Acta Biomater. 8, 1616 (2012).
37. J. M. Holzwarth and P. X. Ma, Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 32, 9622 (2012).
38. S. Scaglione, V. Guarino, M. Sandri, A. Tampieri, L. Ambrosio, and R. Quarto, In vivo lamellar bone formation in fibre coated MgCHA-PCL-composite scaffolds. J. Mater. Sci.: Mater. Med. 23, 117 (2012).
39. D. Suarez-Gonzalez, K. Barnhart, F. Migneco, C. Flanagan, S. J. Hollister, and W. L. Murphy, Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials 33, 713 (2012).